Sesamin directed the epithelial differentiation of cancer stem-like side population cells from gallbladder cancer, which is negatively associated with the NF-κB/IL-6/STAT3/Twist signaling pathway 35. The gene discussed is NFKB1; the disease is gallbladder cancer.